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collection, while 8 (5%) declined to participate. The remaining 125 agreed to participate.
The 125 patients had a mean age of 44.4 years (standard deviation, SD=9.20; age range: 14 -72). Sixty-two were allocated to the PCA group and 63 to the IM group by computer-generated randomisation. There were no significant differences in the baseline characteristics of the patients.
Study design
The study was an unblinded, prospective, randomised controlled trial that was carried out at a single centre. The research assistant and ward staff were blinded to the research hypotheses, to reduce the influence of preconceived expectation. The patients were followed up for 24 hours. Assessments were performed 30 minutes after the patient arrived back in the ward, then every 2 hours for the first 4 hours, every 6 hours for the next 18 hours, and then at 24 hours. No loss to follow-up was reported. Prior to the study, a pilot study was conducted to modify some wording in the nursing activity chart and to amend the inclusion criteria.
Analysis of effectiveness
Although not explicitly stated, it appears that the basis for the clinical analysis was intention to treat. The health outcomes used were: the level of pain while at rest and during motion, the level of satisfaction with pain management, the amount of morphine used, side effects (i.e. the occurrence of nausea, vomiting, dizziness and itching), and the pain-related nursing time.
The level of pain was measured by using visual analogue scales (ranging from 0 to 100). The level of satisfaction with pain management was assessed using a patient satisfaction questionnaire.
Effectiveness results
The mean level of pain at rest was 15.84 points (SD=9.27) for the PCA group and 27.67 points (SD=16.44) for the IM group. The difference of 11.83 points (95% confidence interval, CI: 7.14 -16.52) was significant, (p<0.001).
The mean level of pain during motion was 30.80 points (SD=14.96) for the PCA group and 42.53 points (SD=17.82) for the IM group. The difference of 11.73 points (95% CI: 5.96 -17.50) was significant, (p<0.001).
The mean satisfaction level with pain management was 28.84 (SD=2.70) for the PCA group and 26.03 (SD=2.54) for the IM group. The difference of 2.81 (95% CI: 1.98 -3.73) was significant, (p<0.001).
The total amount of morphine used was 45.65 (SD=27.96) for the PCA group and 22.35 (SD=11.56) for the IM group. The difference of 23.30 (95% CI: 15.82 -30.78) was significant, (p<0.001).
Nausea occurred in 64.9% of the PCA group and 35.1% of the IM group. The difference of 29.8% (95% CI: 0.25 -35.9) was significant, (p<0.003). In terms of the occurrence of vomiting, dizziness and itching, both groups were not significantly different.
Clinical conclusions
PCA was more effective than conventional IM injections after laparotomy for gynaecological surgery, although patients on PCA had more nausea.
were comparable in terms of their demographics and baseline characteristics. The study sample was shown to be representative of the study population. Appropriate statistical analyses were performed to ensure the accuracy of the comparison.
Validity of estimate of measure of benefit
No summary measure of benefit was used in the study as a cost-consequences analysis was conducted. The reader is therefore referred to the comments in the 'Validity of estimate of measure of effectiveness' field (above).
Validity of estimate of costs
The authors did not report the perspective adopted in the analysis. It appears, however, that most of the direct costs incurred by the health service have been included. The costs and the quantities were reported separately, which will enhance the generalisability to other settings. A statistical analysis of resources used and sensitivity analysis of the unit costs were not carried out. The price year was not stated, thus hampering any possible reflation exercises.
Other issues
The authors made appropriate comparisons of their findings with those from other studies, and gave reasons for the differences among the findings. The issue of generalisability to other settings was discussed by comparing the findings with those from studies of patients undergoing other types of surgery. The authors did not present their results selectively and their conclusions reflected the scope of the study. The authors commented on the limitations of their analysis. For example, the absence of details on the type and duration of surgery may make it difficult to deal with potential confounding factors.
Implications of the study
The study implied that PCA was more effective than IM injection after laparotomy for gynaecological surgery, although it was more costly and patients had more nausea, because it resulted in a considerable gain in pain control and, hence, more patient satisfaction with pain management.
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